<bill session="118" type="s" number="1038" updated="2025-11-19T03:14:57Z">
  <state datetime="2023-03-29">REFERRED</state>
  <status>
    <introduced datetime="2023-03-29"/>
  </status>
  <introduced datetime="2023-03-29"/>
  <titles>
    <title type="display">Drug Price Transparency in Medicaid Act of 2023</title>
    <title type="short" as="introduced">Drug Price Transparency in Medicaid Act of 2023</title>
    <title type="official" as="introduced">A bill to amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.</title>
  </titles>
  <sponsor bioguide_id="W000800"/>
  <cosponsors>
    <cosponsor bioguide_id="C001047" joined="2023-05-03"/>
    <cosponsor bioguide_id="G000555" joined="2024-04-30"/>
    <cosponsor bioguide_id="M001198" joined="2023-03-29"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-29">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-03-29" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="3561" relation="unknown"/>
    <bill session="118" type="h" number="1613" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Congressional oversight"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Home and outpatient care"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Retail and wholesale trades"/>
    <term name="State and local government operations"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <summary date="2023-04-19T15:42:30Z" status="Introduced in Senate">Drug Price Transparency in Medicaid Act of 2023

This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.</summary>
</bill>
